Craneware (CRW) Share Price, News & Analysis

Company Overview

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.

Key Stats

• Today's Range: 1,018 to 1,066
• 50-Day Range: 998 to 1,394
• 52-Week Range: 988 to 2,450
• Volume: 163,438 shs
• Average Volume: 721,680 shs
• Market Capitalization: £348.53 million
• P/E Ratio: 16.18
• Dividend Yield: 3.07%
• Price Target: GBX 1,673.33
• Consensus Rating: Buy

Craneware Stock Analysis - MarketRank™

Craneware scored higher than 83% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Buy

Consensus Rating

Craneware has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 3 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

Craneware has a consensus price target of GBX 1,673.33, representing about 64.4% upside from its current price of GBX 1,018.

Amount of Analyst Coverage

Craneware has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Craneware is 16.18, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.90.

Price to Earnings Ratio vs. Sector

The P/E ratio of Craneware is 16.18, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.33.

Price to Book Value per Share Ratio

Craneware has a P/B Ratio of 1.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for CRW.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Craneware pays a meaningful dividend of 3.07%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Craneware does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Craneware is 66.71%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.88

News Sentiment

Craneware has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Craneware this week, compared to 0 articles on an average week.

Company Ownership

• Score: 2.9 / 5
• Insider Trading: Selling Shares

Cluster Insider Buying

3 insiders have purchased shares of Craneware in the last three months. Multiple insiders buying is a strong bullish signal.

Insider Buying vs. Insider Selling

In the past three months, Craneware insiders have sold 23.99% more of their company's stock than they have bought. Specifically, they have bought £122,343 in company stock and sold £151,689.60 in company stock.

Percentage Held by Insiders

10.32% of the stock of Craneware is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

33.64% of the stock of Craneware is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: LON:CRW
• CIK: N/A
• Web: public.craneware.com
• Phone: +44-131-5503100
• Fax: N/A
• Employees: 734
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Craneware: GBX 1,673.33
• High Price Target: GBX 2,850
• Low Price Target: GBX 570
• Potential Upside/Downside: +64.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 62.90
• Trailing P/E Ratio: 16.18
• Forward P/E Ratio: 12.96
• P/E Growth: N/A
• Net Income: £14.27 million
• Net Margins: 9.58%
• Pretax Margin: N/A
• Return on Equity: 5.94%
• Return on Assets: 2.28%

Debt

• Debt-to-Equity Ratio: 14.60
• Current Ratio: 0.83
• Quick Ratio: 1.00

Sales & Book Value

• Annual Sales: £205.96 million
• Price / Sales: 1.69
• Cash Flow: GBX 69.17 per share
• Price / Cash Flow: 14.72
• Book Value: GBX 932.46 per share
• Price / Book: 1.09

Miscellaneous

• Outstanding Shares: 34,237,000
• Free Float: N/A
• Market Cap: £348.53 million
• Optionable: Not Optionable
• Beta: 0.28